Infinity Pharmaceuticals to Present at UBS ConferenceCAMBRIDGE, Mass., Sep 12, 2011 (GlobeNewswire via COMTEX) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) will be presenting at UBS Global Life Sciences Conference on Monday, September 19, 2011 at 2:00 p.m. ET in New York City.
A live webcast of Infinity's presentation will be accessible on the "investors/media" section of the company's website, www.infi.com, and will be available for 30 days following the event.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity's programs in the inhibition of the Hedgehog pathway, the Hsp90 chaperone system, phosphoinositide-3-kinase and fatty acid amide hydrolase are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company's website at www.infi.com.
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Infinity Pharmaceuticals, Inc.
CONTACT: Infinity Pharmaceuticals, Inc.
Jaren Irene Madden, 617-453-1336
Jaren.Madden@infi.com
http://www.infi.com
|
Infinity Pharmaceuticals, Inc.
